VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,639 | -81.3% | 43,898 | -71.5% | 0.00% | – |
| Q2 2023 | $1,016,357 | +8.0% | 154,227 | +11.2% | 0.00% | – |
| Q1 2023 | $941,455 | -9.1% | 138,653 | -1.1% | 0.00% | – |
| Q4 2022 | $1,036,210 | -23.1% | 140,218 | +2.8% | 0.00% | -100.0% |
| Q3 2022 | $1,348,000 | -8.4% | 136,382 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $1,471,000 | -2.7% | 134,874 | +0.9% | 0.00% | – |
| Q1 2022 | $1,512,000 | -28.6% | 133,651 | -1.0% | 0.00% | -100.0% |
| Q4 2021 | $2,118,000 | -5.2% | 134,998 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $2,234,000 | -12.5% | 130,322 | +9.8% | 0.00% | 0.0% |
| Q2 2021 | $2,554,000 | +10.1% | 118,712 | -23.1% | 0.00% | 0.0% |
| Q1 2021 | $2,320,000 | +16.4% | 154,422 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $1,993,000 | +35.8% | 151,705 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $1,468,000 | -14.6% | 151,969 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $1,718,000 | +16.4% | 150,163 | +5.4% | 0.00% | 0.0% |
| Q1 2020 | $1,476,000 | -34.9% | 142,468 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $2,269,000 | +33.6% | 138,292 | +8.2% | 0.00% | 0.0% |
| Q3 2019 | $1,698,000 | -3.2% | 127,870 | +2.7% | 0.00% | 0.0% |
| Q2 2019 | $1,754,000 | -23.3% | 124,505 | +0.2% | 0.00% | 0.0% |
| Q1 2019 | $2,287,000 | -21.2% | 124,291 | +11.2% | 0.00% | -50.0% |
| Q4 2018 | $2,902,000 | +13.2% | 111,750 | +0.1% | 0.00% | 0.0% |
| Q3 2018 | $2,563,000 | +1564.3% | 111,631 | +1283.3% | 0.00% | – |
| Q2 2018 | $154,000 | +13.2% | 8,070 | +0.1% | 0.00% | – |
| Q1 2018 | $136,000 | -22.7% | 8,065 | -30.4% | 0.00% | – |
| Q4 2017 | $176,000 | -22.5% | 11,595 | -8.4% | 0.00% | – |
| Q3 2017 | $227,000 | +25.4% | 12,663 | +14.0% | 0.00% | – |
| Q2 2017 | $181,000 | +60.2% | 11,105 | +37.4% | 0.00% | – |
| Q1 2017 | $113,000 | -13.7% | 8,083 | -1.5% | 0.00% | – |
| Q4 2016 | $131,000 | +37.9% | 8,205 | +41.3% | 0.00% | – |
| Q3 2016 | $95,000 | +33.8% | 5,806 | -9.7% | 0.00% | – |
| Q2 2016 | $71,000 | +36.5% | 6,427 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -14.8% | 6,427 | 0.0% | 0.00% | – |
| Q4 2015 | $61,000 | -16.4% | 6,427 | 0.0% | 0.00% | – |
| Q3 2015 | $73,000 | -11.0% | 6,427 | 0.0% | 0.00% | – |
| Q2 2015 | $82,000 | +36.7% | 6,427 | 0.0% | 0.00% | – |
| Q1 2015 | $60,000 | -37.5% | 6,427 | 0.0% | 0.00% | – |
| Q4 2014 | $96,000 | +43.3% | 6,427 | 0.0% | 0.00% | – |
| Q3 2014 | $67,000 | – | 6,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |